期刊文献+

慢病毒介导shRNA沉默LAMP-2A和TSG101表达对PC12细胞中EGFP-α-synuclein(A53T)降解的影响

Effect of lentivirus-mediated LAMP-2A and TSG101 silencing on EGFP-α-synuclein(A53T) degradation in PC12 cells
下载PDF
导出
摘要 目的采用慢病毒介导的shRNA干扰技术,下调PC12细胞中溶酶体相关膜蛋白-2A(lysosome-associated membrane protein type 2A,LAMP-2A)和肿瘤易感基因101(tumor susceptibility gene101,TSG101)的表达,并研究其对EGFP-α-synuclein(A53T)降解的影响。方法以LAMP-2A和TSG101为靶基因,合成寡核苷酸,退火形成双链DNA,与经Bam HⅠ、EcoRⅠ双酶切的p HBLV-U6-Puro载体连接获得重组慢病毒载体;将其与病毒包装辅助质粒共感染293T细胞,收集并浓缩上清液获得重组病毒,测定病毒滴度;病毒颗粒转染PC12细胞,经嘌呤酶素筛选获得稳定感染细胞株;Western blot检测LAMP-2A和TSG101蛋白的表达;分别采用LAMP-2A shRNA2和TSG101 shRNA1下调PC12细胞中LAMP-2A和TSG101蛋白的表达,并结合巴佛洛霉素A1处理,研究其对PC12细胞中EGFP-α-synuclein(A53T)、EGFP、α-synuclein(A53T)和LC3B蛋白的影响,免疫荧光检测各组PC12细胞中EGFP-α-synuclein(A53T)和LC3B蛋白的表达。结果成功构建干扰LAMP-2A和TSG101表达的慢病毒载体,并在293T细胞中包装获得病毒。重组病毒感染PC12细胞后,Western blot检测结果显示LAMP-2A shRNA2和TSG101 shRNA1干扰效果最好;下调LAMP-2A和TSG101蛋白表达均能够抑制细胞中EGFP-α-synuclein(A53T)、EGFP和α-synuclein(A53T)蛋白的降解(P<0.01),并提高LC3-Ⅱ蛋白的含量(P<0.01)。结论慢病毒介导的shRNA能有效地沉默PC12细胞中LAMP-2A和TSG101的表达,抑制细胞中EGFP-α-synuclein(A53T)的降解。 Objective To suppress the gene expression of lysosome-associated membrane protein type2A( LAMP-2A) and tumor susceptibility gene 101( TSG101) by lentiviruses,and observe its impact on EGFP-α-synuclein( A53T) degradation in PC12 cells. Methods Synthesized oligonucleotides were cloned into the lentiviral vectors p HBLV-U6-Puro which was digested with Bam HⅠ and EcoRⅠ. The recombinant vectors were verified by sequencing,and transferred into 293 T package cells together with helper vectors.Recombinant lentiviruses were extracted from cell cultures to transfect PC12 cells. Stably transfected cells were screened with puromycin,and the expression of LAMP-2A and TSG101 was determined by Western blotting.The expression of LAMP-2A and TSG101 was suppressed by lentiviruses LAMP-2A shRNA2 and TSG101shRNA1,respectively,and after treatment with bafilomycin A1,the expression of enhanced green fluorescent protein( EGFP)-α-synuclein( A53T),EGFP,α-synuclein( A53T) and LC3 B protein in PC12 cells was observed. The expression of EGFP-α-synuclein( A53T) and LC3 B protein were examined by immunofluorescence assay. Results Recombinant vectors were successfully constructed, and sufficient lentiviruses were obtained from the package cells. The recombinant lentiviruses could efficiently transfect PC12 cells,and 2 clones transfected with lentiviruses LAMP-2A shRNA2 and TSG101 shRNA1,respectively,were screened. The results of Western blotting showed that LAMP-2A and TSG101 expression was efficiently suppressed in PC12 cells. The degradation of EGFP-α-synuclein( A53T),EGFP and α-synuclein( A53T) was significantly suppressed( P〈0. 01),and the expression of LC3-Ⅱwas increased( P〈0. 01). Conclusion RNAi technology based on lentivirus can efficiently suppress the gene expression of LAMP-2A and TSG101,and inhibit the degradation of EGFP-α-synuclein( A53T) in PC12 cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2015年第14期1393-1399,共7页 Journal of Third Military Medical University
基金 国家自然科学基金青年基金(31201045) 四川省应用基础研究计划(2012JY0113) 四川省教育厅科研项目(13ZB0094) 成都医学院自然科学基金(CYZ11-007)~~
关键词 溶酶体相关膜蛋白-2A 肿瘤易感基因101 慢病毒 α-突触蛋白 PC12细胞 lysosome-associated membrane protein type 2A tumor susceptibility gene 101 lentivirus α-synuclein PC12 cells
  • 相关文献

参考文献3

二级参考文献100

  • 1Nied: :4edzka-Rystwej P, Tokarz-Deptu:a B, Deptu:a W. Autophagy in physiological and pathological processes-selected aspects[ J]. Pol J Vet Sci, 2013, 16(1) : 173 - 180.
  • 2Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating [Jl. Ceil Mol Life Sci, 2012, 69(7): 1125 -1136.
  • 3Benbrook DM, Long A. Integration of autophagy, pmteasomal degradation, unfolded protein response and apoptosis [ J]. Exp Oncol, 2012, 34 ( 3 ) : 286 - 2897.
  • 4Kon M, Kiffin R, Koga H, et al. Chaperone-mediated autophagy is required for tumor growth[J]. Sci Transl Med, 2011, 3(109) : 109 -117.
  • 5Saha T. LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy [ J ]. Autophagy, 2012, 8(11) : 1643 -1656.
  • 6Li W, Yang Q, Mao Z. Chaperone-mediated autophagy: machinery, regulation and biological consequences[J]. Cell Mol Life Sci, 2011, 68 ( 5 ) : 749 - 763.
  • 7Ciruelos E, Cortes-Funes H, Ghanem I, et al. Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer[J]. Anticancer Drugs, 2013, 24(8) : 769 -780.
  • 8Cortes J, Baselga J. Targeting the microtubtdes in breast cancer beyond taxanes : the epothilones [ J ]. Oncologist, 2007, 12 ( 3 ) : 271 - 280.
  • 9Kimura T, Takabatake Y, Takahashi A, et al. Chloroquine in cancer therapy : a double-edged sword of autophagy [ J ]. Cancer Res, 2013, 73(1): 3-7.
  • 10Zou CF, Jia L, Jin H, eta|. Re-expression of ARH1 (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel[ J/OA 1. BMC Cancer, 2011, 11 : 22.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部